{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:42:07Z","timestamp":1783953727292,"version":"3.55.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-148821"],"award-info":[{"award-number":["PJT-148821"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-156225"],"award-info":[{"award-number":["PJT-156225"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.neo.2022.100874","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T12:53:42Z","timestamp":1673441622000},"page":"100874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["S-adenosylmethionine blocks tumorigenesis and with immune checkpoint inhibitor enhances anti-cancer efficacy against BRAF mutant and wildtype melanomas"],"prefix":"10.1016","volume":"36","author":[{"given":"A.","family":"Mehdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8090-0425","authenticated-orcid":false,"given":"M.","family":"Attias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Arakelian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Szyf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.","family":"Piccirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Rabbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10151","key":"10.1016\/j.neo.2022.100874_bib0001","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","article-title":"Melanoma","volume":"392","author":"Schadendorf","year":"2018","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.neo.2022.100874_bib0002","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic Classification of Cutaneous Melanoma","volume":"161","author":"Network","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.neo.2022.100874_bib0003","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5269062","article-title":"Long-Term Survival, Quality of Life, and Psychosocial Outcomes in Advanced Melanoma Patients Treated with Immune Checkpoint Inhibitors","volume":"2019","author":"Rogiers","year":"2019","journal-title":"J Oncol"},{"key":"10.1016\/j.neo.2022.100874_bib0004","first-page":"313","article-title":"Clinical utility of nivolumab in the treatment of advanced melanoma","volume":"12","author":"Asmar","year":"2016","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"10.1016\/j.neo.2022.100874_bib0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.neo.2022.100874_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2019.12.010","article-title":"Resistance to Checkpoint Inhibition in Cancer Immunotherapy","volume":"13","author":"Barrueto","year":"2020","journal-title":"Transl Oncol"},{"issue":"1","key":"10.1016\/j.neo.2022.100874_bib0007","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ccr.2013.05.009","article-title":"Directed phenotype switching as an effective antimelanoma strategy","volume":"24","author":"Saez-Ayala","year":"2013","journal-title":"Cancer Cell"},{"issue":"19-20","key":"10.1016\/j.neo.2022.100874_bib0008","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1101\/gad.329771.119","article-title":"Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities","volume":"33","author":"Rambow","year":"2019","journal-title":"Genes Dev,"},{"issue":"20","key":"10.1016\/j.neo.2022.100874_bib0009","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1038\/onc.2010.598","article-title":"Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny","volume":"30","author":"Cheli","year":"2011","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.neo.2022.100874_bib0010","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1158\/0008-5472.CAN-07-2491","article-title":"In vivo switching of human melanoma cells between proliferative and invasive states","volume":"68","author":"Hoek","year":"2008","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.neo.2022.100874_bib0011","article-title":"Signaling Pathways in Melanogenesis","volume":"17","author":"D'Mello","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.neo.2022.100874_bib0012","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1111\/j.1467-789X.2010.00773.x","article-title":"Melanin and melanogenesis in adipose tissue: possible mechanisms for abating oxidative stress and inflammation?","volume":"12","author":"Page","year":"2011","journal-title":"Obes Rev"},{"issue":"9","key":"10.1016\/j.neo.2022.100874_bib0013","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.molmed.2006.07.008","article-title":"MITF: master regulator of melanocyte development and melanoma oncogene","volume":"12","author":"Levy","year":"2006","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.neo.2022.100874_bib0014","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.critrevonc.2017.05.001","article-title":"Melanoma antigens and related immunological markers","volume":"115","author":"Pitcovski","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"issue":"7420","key":"10.1016\/j.neo.2022.100874_bib0015","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nature11538","article-title":"Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation","volume":"490","author":"Landsberg","year":"2012","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.neo.2022.100874_bib0016","first-page":"131","article-title":"Inhibiting the MNK1\/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses","author":"Huang","year":"2021","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.neo.2022.100874_bib0017","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1158\/1078-0432.CCR-14-1860","article-title":"Immune escape mechanisms as a guide for cancer immunotherapy","volume":"21","author":"Beatty","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"7463","key":"10.1016\/j.neo.2022.100874_bib0018","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.neo.2022.100874_bib0019","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1056\/NEJMc1713444","article-title":"Tumor Mutational Burden and Response Rate to PD-1 Inhibition","volume":"377","author":"Yarchoan","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neo.2022.100874_bib0020","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.3389\/fonc.2020.01152","article-title":"Role of DNA Methylation in the Resistance to Therapy in Solid Tumors","volume":"10","author":"Romero-Garcia","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.neo.2022.100874_bib0021","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1038\/s41467-019-12159-9","article-title":"DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load","volume":"10","author":"Jung","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.neo.2022.100874_bib0022","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3389\/fonc.2020.01361","article-title":"Enhanced Anticancer Effect of a Combination of S-adenosylmethionine (SAM) and Immune Checkpoint Inhibitor (ICPi) in a Syngeneic Mouse Model of Advanced Melanoma","volume":"10","author":"Mehdi","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.neo.2022.100874_bib0023","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41413-020-0103-6","article-title":"An enhanced chemopreventive effect of methyl donor S-adenosylmethionine in combination with 25-hydroxyvitamin D in blocking mammary tumor growth and metastasis","volume":"8","author":"Mahmood","year":"2020","journal-title":"Bone Res"},{"issue":"5","key":"10.1016\/j.neo.2022.100874_bib0024","doi-asserted-by":"crossref","first-page":"1151S","DOI":"10.1093\/ajcn\/76.5.1151S","article-title":"S-Adenosyl-L-methionine (SAMe): from the bench to the bedside\u2013molecular basis of a pleiotrophic molecule","volume":"76","author":"Bottiglieri","year":"2002","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1016\/j.neo.2022.100874_bib0025","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jnutbio.2007.05.010","article-title":"Ethanol inhibits methionine adenosyltransferase II activity and S-adenosylmethionine biosynthesis and enhances caspase-3-dependent cell death in T lymphocytes: relevance to alcohol-induced immunosuppression","volume":"19","author":"Hote","year":"2008","journal-title":"J Nutr Biochem"},{"issue":"Pt 3","key":"10.1016\/j.neo.2022.100874_bib0026","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1042\/bj3190929","article-title":"Interleukin-2 induces gamma-S-adenosyl-L-methionine synthetase gene expression during T-lymphocyte activation","volume":"319","author":"Tobena","year":"1996","journal-title":"Biochem J"},{"issue":"25","key":"10.1016\/j.neo.2022.100874_bib0027","doi-asserted-by":"crossref","first-page":"16040","DOI":"10.1074\/jbc.272.25.16040","article-title":"Differential regulation of methionine adenosyltransferase in superantigen and mitogen stimulated human T lymphocytes","volume":"272","author":"LeGros","year":"1997","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.neo.2022.100874_bib0028","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4049\/jimmunol.139.1.202","article-title":"Stimulation of S-adenosylmethionine synthetase in human lymphocytes by streptococcal M protein","volume":"139","author":"Kotb","year":"1987","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.neo.2022.100874_bib0029","first-page":"3361","article-title":"Induction of interleukin 2 production but not methionine adenosyltransferase activity or S-adenosylmethionine turnover in Jurkat T-cells","volume":"52","author":"De La Rosa","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2022.100874_bib0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2682-1","article-title":"Cancer SLC43A2 alters T cell methionine metabolism and histone methylation","author":"Bian","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.neo.2022.100874_bib0031","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nchembio.1204","article-title":"NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink","volume":"9","author":"Ulanovskaya","year":"2013","journal-title":"Nat Chem Biol"},{"issue":"5","key":"10.1016\/j.neo.2022.100874_bib0032","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.neo.2022.100874_bib0033","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.neo.2022.100874_bib0034","doi-asserted-by":"crossref","DOI":"10.1093\/database\/bav097","article-title":"MGDB: a comprehensive database of genes involved in melanoma","volume":"2015","author":"Zhang","year":"2015","journal-title":"Database (Oxford)"},{"issue":"1","key":"10.1016\/j.neo.2022.100874_bib0035","doi-asserted-by":"crossref","first-page":"9280","DOI":"10.1038\/s41598-019-45643-9","article-title":"Melanin presence inhibits melanoma cell spread in mice in a unique mechanical fashion","volume":"9","author":"Sarna","year":"2019","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.neo.2022.100874_bib0036","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/exd.12535","article-title":"Cell elasticity is an important indicator of the metastatic phenotype of melanoma cells","volume":"23","author":"Sarna","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.neo.2022.100874_bib0037","article-title":"B16 as a mouse model for human melanoma","author":"Overwijk","year":"2001","journal-title":"Curr Protoc Immunol,"},{"issue":"1","key":"10.1016\/j.neo.2022.100874_bib0038","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jdermsci.2013.03.012","article-title":"Effects of fibroblast-derived factors on the proliferation and differentiation of human melanocytes in culture","volume":"71","author":"Hirobe","year":"2013","journal-title":"J Dermatol Sci"},{"issue":"1","key":"10.1016\/j.neo.2022.100874_bib0039","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5114\/pdia.2013.33376","article-title":"Skin melanocytes: biology and development","volume":"30","author":"Cichorek","year":"2013","journal-title":"Postepy Dermatol Alergol"},{"issue":"6","key":"10.1016\/j.neo.2022.100874_bib0040","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1755-148X.2008.00505.x","article-title":"Novel MITF targets identified using a two-step DNA microarray strategy","volume":"21","author":"Hoek","year":"2008","journal-title":"Pigment Cell Melanoma Res"},{"issue":"7","key":"10.1016\/j.neo.2022.100874_bib0041","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/jid.2010.69","article-title":"Heterogeneous phenotype of human melanoma cells with in vitro and in vivo features of tumor-initiating cells","volume":"130","author":"Perego","year":"2010","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.neo.2022.100874_bib0042","doi-asserted-by":"crossref","DOI":"10.3390\/cancers8030034","article-title":"Melanoma Cancer Stem Cells: Markers and Functions","volume":"8","author":"Parmiani","year":"2016","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.neo.2022.100874_bib0043","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nm0596-574","article-title":"Involvement of the CD95 (APO-1\/FAS) receptor\/ligand system in drug-induced apoptosis in leukemia cells","volume":"2","author":"Friesen","year":"1996","journal-title":"Nat Med"},{"issue":"5291","key":"10.1016\/j.neo.2022.100874_bib0044","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1126\/science.274.5291.1363","article-title":"Melanoma cell expression of Fas(Apo-1\/CD95) ligand: implications for tumor immune escape","volume":"274","author":"Hahne","year":"1996","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neo.2022.100874_bib0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1152\/physrev.00045.2017","article-title":"The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond","volume":"99","author":"Dostert","year":"2019","journal-title":"Physiol Rev"},{"issue":"5","key":"10.1016\/j.neo.2022.100874_bib0046","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ijc.1378","article-title":"Drug-resistance in human melanoma","volume":"93","author":"Helmbach","year":"2001","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.neo.2022.100874_bib0047","first-page":"1055","article-title":"Role of inhibitor of growth 4 in the suppression of human melanoma cells through the Fas\/FasL-mediated apoptosis pathway","volume":"41","author":"Cai","year":"2018","journal-title":"Int J Mol Med"},{"issue":"3","key":"10.1016\/j.neo.2022.100874_bib0048","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1158\/2159-8290.CD-20-0756","article-title":"A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy","volume":"11","author":"Upadhyay","year":"2021","journal-title":"Cancer Discov"},{"issue":"10","key":"10.1016\/j.neo.2022.100874_bib0049","first-page":"2703","article-title":"Endogenous interleukin-18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates","volume":"60","author":"Cho","year":"2000","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.neo.2022.100874_bib0050","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1521-4141(199901)29:01<45::AID-IMMU45>3.0.CO;2-I","article-title":"ICAM-1 and B7-1 provide similar but distinct costimulation for CD8+ T cells, while CD4+ T cells are poorly costimulated by ICAM-1","volume":"29","author":"Deeths","year":"1999","journal-title":"Eur J Immunol"},{"issue":"9","key":"10.1016\/j.neo.2022.100874_bib0051","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.4049\/jimmunol.163.9.4826","article-title":"Defective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling","volume":"163","author":"Shier","year":"1999","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.neo.2022.100874_bib0052","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.4049\/jimmunol.174.6.3416","article-title":"ICAM-1 contributes to but is not essential for tumor antigen cross-priming and CD8+ T cell-mediated tumor rejection in vivo","volume":"174","author":"Blank","year":"2005","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.neo.2022.100874_bib0053","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/jsre.1997.5242","article-title":"Enhanced cytolytic activity of tumor infiltrating lymphocytes (TILs) derived from an ICAM-1 transfected tumor in a murine model","volume":"75","author":"Lefor","year":"1998","journal-title":"J Surg Res"},{"issue":"1","key":"10.1016\/j.neo.2022.100874_bib0054","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1006\/jsre.1995.1133","article-title":"Enhanced expression of ICAM-1 in a murine fibrosarcoma reduces tumor growth rate","volume":"59","author":"Sartor","year":"1995","journal-title":"J Surg Res"},{"issue":"3","key":"10.1016\/j.neo.2022.100874_bib0055","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3892\/mmr.2014.2914","article-title":"Ki67 is a promising molecular target in the diagnosis of cancer (review)","volume":"11","author":"Li","year":"2015","journal-title":"Mol Med Rep"},{"issue":"4","key":"10.1016\/j.neo.2022.100874_bib0056","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nature Reviews Cancer"},{"issue":"1","key":"10.1016\/j.neo.2022.100874_bib0057","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1067745","article-title":"Long-lasting multifunctional CD8(+) T cell responses in end-stage melanoma patients can be induced by dendritic cell vaccination","volume":"5","author":"Wimmers","year":"2016","journal-title":"Oncoimmunology"},{"issue":"23","key":"10.1016\/j.neo.2022.100874_bib0058","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1038\/sj.onc.1207565","article-title":"Loss of tyrosinase activity confers increased skin tumor susceptibility in mice","volume":"23","author":"Saran","year":"2004","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.neo.2022.100874_bib0059","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/labinvest.3700669","article-title":"Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations","volume":"87","author":"Prud'homme","year":"2007","journal-title":"Lab Invest"},{"issue":"5","key":"10.1016\/j.neo.2022.100874_bib0060","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.immuni.2009.09.014","article-title":"T helper 17 cells promote cytotoxic T cell activation in tumor immunity","volume":"31","author":"Martin-Orozco","year":"2009","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.neo.2022.100874_bib0061","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1600-0749.2006.00322.x","article-title":"Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature","volume":"19","author":"Hoek","year":"2006","journal-title":"Pigment Cell Res"},{"issue":"24","key":"10.1016\/j.neo.2022.100874_bib0062","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1101\/gad.406406","article-title":"Mitf regulation of Dia1 controls melanoma proliferation and invasiveness","volume":"20","author":"Carreira","year":"2006","journal-title":"Genes Dev"},{"issue":"1","key":"10.1016\/j.neo.2022.100874_bib0063","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12943-020-01290-7","article-title":"The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor?","volume":"19","author":"Ballotti","year":"2020","journal-title":"Mol Cancer"},{"issue":"7047","key":"10.1016\/j.neo.2022.100874_bib0064","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature03664","article-title":"Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma","volume":"436","author":"Garraway","year":"2005","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.neo.2022.100874_bib0065","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/jid.2014.319","article-title":"Pro-survival role of MITF in melanoma","volume":"135","author":"Hartman","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.neo.2022.100874_bib0066","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/path.4318","article-title":"Molecular and genetic diversity in the metastatic process of melanoma","volume":"233","author":"Harbst","year":"2014","journal-title":"J Pathol"},{"issue":"19","key":"10.1016\/j.neo.2022.100874_bib0067","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1038\/onc.2011.425","article-title":"Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells","volume":"31","author":"Cheli","year":"2012","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.neo.2022.100874_bib0068","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/jid.2013.340","article-title":"Transcription factor\/microRNA axis blocks melanoma invasion program by miR-211 targeting NUAK1","volume":"134","author":"Bell","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.neo.2022.100874_bib0069","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.tranon.2018.10.014","article-title":"Microphthalmia-Associated Transcription Factor (MITF) Regulates Immune Cell Migration into Melanoma","volume":"12","author":"Wiedemann","year":"2019","journal-title":"Transl Oncol"},{"key":"10.1016\/j.neo.2022.100874_bib0070","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.63093","article-title":"MITF reprograms the extracellular matrix and focal adhesion in melanoma","volume":"10","author":"Dilshat","year":"2021","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.neo.2022.100874_bib0071","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cell.2018.06.025","article-title":"Toward Minimal Residual Disease-Directed Therapy in Melanoma","volume":"174","author":"Rambow","year":"2018","journal-title":"Cell"},{"issue":"22","key":"10.1016\/j.neo.2022.100874_bib0072","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1158\/0008-5472.CAN-19-0037","article-title":"Zebrafish MITF-Low Melanoma Subtype Models Reveal Transcriptional Subclusters and MITF-Independent Residual Disease","volume":"79","author":"Travnickova","year":"2019","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.neo.2022.100874_bib0073","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1158\/2159-8290.CD-17-1178","article-title":"Immunotherapy Resistance by Inflammation-Induced Dedifferentiation","volume":"8","author":"Mehta","year":"2018","journal-title":"Cancer Discov"},{"issue":"13","key":"10.1016\/j.neo.2022.100874_bib0074","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110582","article-title":"PRMT7 ablation stimulates anti-tumor immunity and sensitizes melanoma to immune checkpoint blockade","volume":"38","author":"Srour","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.neo.2022.100874_bib0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.abb.2014.07.019","article-title":"The roles of microphthalmia-associated transcription factor and pigmentation in melanoma","volume":"563","author":"Hsiao","year":"2014","journal-title":"Arch Biochem Biophys"},{"issue":"13","key":"10.1016\/j.neo.2022.100874_bib0076","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1158\/0008-5472.CAN-10-0118","article-title":"Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function","volume":"70","author":"Boni","year":"2010","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.neo.2022.100874_bib0077","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1182\/blood-2009-03-211714","article-title":"Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.neo.2022.100874_bib0078","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4049\/jimmunol.169.2.642","article-title":"Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis","volume":"169","author":"Starnes","year":"2002","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.neo.2022.100874_bib0079","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.celrep.2014.03.073","article-title":"Interleukin-17D mediates tumor rejection through recruitment of natural killer cells","volume":"7","author":"O'Sullivan","year":"2014","journal-title":"Cell Rep"},{"issue":"9","key":"10.1016\/j.neo.2022.100874_bib0080","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1016\/j.celrep.2016.07.075","article-title":"Nrf2 Induces IL-17D to Mediate Tumor and Virus Surveillance","volume":"16","author":"Saddawi-Konefka","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.neo.2022.100874_bib0081","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40364-020-00228-x","article-title":"Roles of IFN-gamma in tumor progression and regression: a review","volume":"8","author":"Jorgovanovic","year":"2020","journal-title":"Biomark Res"},{"issue":"6","key":"10.1016\/j.neo.2022.100874_bib0082","doi-asserted-by":"crossref","first-page":"e2836","DOI":"10.1038\/cddis.2017.67","article-title":"Interferon-gamma derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity","volume":"8","author":"Bhat","year":"2017","journal-title":"Cell Death Dis"},{"issue":"4","key":"10.1016\/j.neo.2022.100874_bib0083","doi-asserted-by":"crossref","first-page":"e12441","DOI":"10.1111\/cpr.12441","article-title":"Anti-cancer therapy with TNFalpha and IFNgamma: A comprehensive review","volume":"51","author":"Shen","year":"2018","journal-title":"Cell Prolif"},{"issue":"1","key":"10.1016\/j.neo.2022.100874_bib0084","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1038\/s41467-020-15546-9","article-title":"Pre-clinical modeling of cutaneous melanoma","volume":"11","author":"Rebecca","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.neo.2022.100874_bib0085","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.18632\/oncotarget.23704","article-title":"Methyl donor S-adenosylmethionine (SAM) supplementation attenuates breast cancer growth, invasion, and metastasis in vivo; therapeutic and chemopreventive applications","volume":"9","author":"Mahmood","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2022.100874_bib0086","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-3-030-22254-3_14","article-title":"Targeting DNA Hypomethylation in Malignancy by Epigenetic Therapies","volume":"1164","author":"Mahmood","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"10.1016\/j.neo.2022.100874_bib0087","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/cam4.386","article-title":"S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: therapeutic and diagnostic clinical applications","volume":"4","author":"Parashar","year":"2015","journal-title":"Cancer Med"},{"issue":"11","key":"10.1016\/j.neo.2022.100874_bib0088","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1592\/phco.24.16.1501.50943","article-title":"Bioavailability and lack of toxicity of S-adenosyl-L-methionine (SAMe) in humans","volume":"24","author":"Goren","year":"2004","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.neo.2022.100874_bib0089","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/cancers15010048","article-title":"Co-Targeting Luminal B Breast Cancer with S-Adenosylmethionine and Immune Checkpoint Inhibitor Reduces Primary Tumor Growth and Progression, and Metastasis to Lungs and Bone","volume":"15","author":"Mehdi","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.neo.2022.100874_bib0090","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1083\/jcb.142.3.827","article-title":"Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes","volume":"142","author":"Bertolotto","year":"1998","journal-title":"J Cell Biol"},{"issue":"3","key":"10.1016\/j.neo.2022.100874_bib0091","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030545","article-title":"Role of Methylation in Pro- and Anti-Cancer Immunity","volume":"13","author":"Mehdi","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.neo.2022.100874_bib0092","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.molimm.2017.04.012","article-title":"Epigenetics and immunotherapy: The current state of play","volume":"87","author":"Dunn","year":"2017","journal-title":"Mol Immunol"},{"issue":"1","key":"10.1016\/j.neo.2022.100874_bib0093","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41598-018-37055-y","article-title":"Quantitative analysis of melanin content in a three-dimensional melanoma cell culture","volume":"9","author":"Chung","year":"2019","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.neo.2022.100874_bib0094","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"3","key":"10.1016\/j.neo.2022.100874_bib0095","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat Genet"},{"issue":"43","key":"10.1016\/j.neo.2022.100874_bib0096","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A,"},{"key":"10.1016\/j.neo.2022.100874_bib0097","doi-asserted-by":"crossref","first-page":"8529","DOI":"10.2147\/CMAR.S215729","article-title":"Beyond The T\/C Ratio: Old And New Anticancer Activity Scores In Vivo","volume":"11","author":"Ubezio","year":"2019","journal-title":"Cancer Manag Res"},{"issue":"2","key":"10.1016\/j.neo.2022.100874_bib0098","first-page":"401","article-title":"A KDR-binding peptide (ST100,059) can block angiogenesis, melanoma tumor growth and metastasis in vitro and in vivo","volume":"39","author":"Rastelli","year":"2011","journal-title":"Int J Oncol"},{"issue":"10","key":"10.1016\/j.neo.2022.100874_bib0099","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/eji.201970107","article-title":"Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)","volume":"49","author":"Cossarizza","year":"2019","journal-title":"Eur J Immunol"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558622000999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558622000999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:14:00Z","timestamp":1761484440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558622000999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":99,"alternative-id":["S1476558622000999"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2022.100874","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S-adenosylmethionine blocks tumorigenesis and with immune checkpoint inhibitor enhances anti-cancer efficacy against BRAF mutant and wildtype melanomas","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2022.100874","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100874"}}